Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9346294rdf:typepubmed:Citationlld:pubmed
pubmed-article:9346294lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:9346294lifeskim:mentionsumls-concept:C0678640lld:lifeskim
pubmed-article:9346294lifeskim:mentionsumls-concept:C1515877lld:lifeskim
pubmed-article:9346294lifeskim:mentionsumls-concept:C0597484lld:lifeskim
pubmed-article:9346294lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9346294lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:9346294lifeskim:mentionsumls-concept:C0074995lld:lifeskim
pubmed-article:9346294pubmed:issue2lld:pubmed
pubmed-article:9346294pubmed:dateCreated1997-11-21lld:pubmed
pubmed-article:9346294pubmed:abstractTextThe effect of sphingosylphosphorylcholine (SphPCho) on the intracellular pH (pHi) in GH4C1 cells was investigated. SphPCho evoked a very slow increase in basal pHi. In cells acidified with nigericin, SphPCho induced a rapid alkalinization of the cells. The effect was inhibited in a Na+-free buffer solution, but was insensitive to ethylisopropyl amiloride, a potent inhibitor of Na+-H+ exchangers (NHE). Reverse transcription and PCR showed that the predominant isoform of the antiport expressed in GH4C1 cells is NHE-1. The rate of alkalinization after stimulation with propionate, and after addition of Na+ to cells acidified with NH4Cl, was enhanced in cells treated with SphPCho. The initial rate of alkalinization after addition of Na+ to acidified cells treated with SphPCho gave an apparent Km value of 15 +/- 2 mM for Na+. The Vmax value was 9 +/- 2 mM H+/min. The effect was insensitive to ouabain, staurosporine and bafilomycin A. However, the SphPCho-evoked alkalinization was abolished in cells treated with 2-deoxy-D-glucose. The effect was not due to the charge of the molecule, as stearylamine increased pHi in Na+-containing and Na+-free buffer. The results show that SphPCho may activate Na+-H+ exchange, and that this effect is mediated via an amiloride-insensitive exchange mechanism.lld:pubmed
pubmed-article:9346294pubmed:languageenglld:pubmed
pubmed-article:9346294pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:citationSubsetIMlld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346294pubmed:statusMEDLINElld:pubmed
pubmed-article:9346294pubmed:monthSeplld:pubmed
pubmed-article:9346294pubmed:issn0014-2956lld:pubmed
pubmed-article:9346294pubmed:authorpubmed-author:GrinsteinSSlld:pubmed
pubmed-article:9346294pubmed:authorpubmed-author:WoodsideMMlld:pubmed
pubmed-article:9346294pubmed:authorpubmed-author:TörnquistKKlld:pubmed
pubmed-article:9346294pubmed:issnTypePrintlld:pubmed
pubmed-article:9346294pubmed:day1lld:pubmed
pubmed-article:9346294pubmed:volume248lld:pubmed
pubmed-article:9346294pubmed:ownerNLMlld:pubmed
pubmed-article:9346294pubmed:authorsCompleteYlld:pubmed
pubmed-article:9346294pubmed:pagination394-400lld:pubmed
pubmed-article:9346294pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:meshHeadingpubmed-meshheading:9346294-...lld:pubmed
pubmed-article:9346294pubmed:year1997lld:pubmed
pubmed-article:9346294pubmed:articleTitleSphingosylphosphorylcholine activates an amiloride-insensitive Na+-H+-exchange mechanism in GH4C1 cells.lld:pubmed
pubmed-article:9346294pubmed:affiliationDepartment of Biosciences, University of Helsinki, Finland.lld:pubmed
pubmed-article:9346294pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9346294pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed